Lisa Gillespie is an Editor at Medscape. She focuses on health care reporting, with a keen interest in medical advancements and policy issues. Lisa has been featured in MDEdge, Medscape, Wood Mackenzie, Cincinnati Enquirer, Yorkshire Post, Kaiser Health News, and MedCity News.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Not enough data
Lisa's articles predominantly focus on health and healthcare, often citing data and government announcements. Given her emphasis on data-driven reporting, she is likely to be interested in pitches that offer access to new or exclusive data related to healthcare, aging, health disparities, Medicare, childhood development, drug abuse or poverty.
Experts who can provide insightful analysis based on the latest studies or government initiatives are also likely to capture Lisa's attention. Pitches offering interviews with researchers or professionals actively involved in addressing these issues could align well with her coverage style.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Lisa Gillespie
Ten women from Greater Cincinnati and Northern Kentucky communities will be honored for their accomplishments.
Physicians, historians, and other experts look back at the rhetoric that framed the birth of Medicare 60 years ago.
By: Lisa Gillespie
Edited by Lisa Gillespie July 29, 2025 The creation of Medicare in 1965 was hailed as a watershed for the social safety net, offering
The Missouri Hospital Association objects to the formula for setting the federal penalties because it does not factor in the number of patients who are poor or in bad health. It is seeking to generate consumer interest in the penalties.
Many Americans believe the U.S. isn’t doing enough to fight prescription painkiller and heroin abuse, reports a Kaiser Family Foundation poll out Tuesday.
A new study from the National Academies of Sciences seeks best practices for health providers whose patients are disproportionately disadvantaged.
The fight against the growing abuse of prescription painkillers and heroin is not robust enough at any level, according to most Americans in a new poll.
A randomized trial finds weekly extended-release buprenorphine yields neonatal outcomes comparable to sublingual treatment.
The Missouri Hospital Association objects to the formula for setting the federal penalties because it does not factor in the number of patients who are poor or in bad health. It is seeking to generate consumer interest in the penalties.
Many Americans believe the U.S. isn’t doing enough to fight prescription painkiller and heroin abuse, reports a Kaiser Family Foundation poll out Tuesday.
